BridgeBio Pharma, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
BridgeBio Pharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • BridgeBio Pharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.6M, a 27.6% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Operating Lease, Payments for 2023 was $4.83M, a 22.7% decline from 2022.
  • BridgeBio Pharma, Inc. annual Operating Lease, Payments for 2022 was $6.25M, a 2.01% increase from 2021.
  • BridgeBio Pharma, Inc. annual Operating Lease, Payments for 2021 was $6.12M, a 46.8% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.83M -$1.42M -22.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $6.25M +$123K +2.01% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $6.12M +$1.95M +46.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $4.17M +$2.17M +108% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $2M Jan 1, 2019 Dec 31, 2019 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.